Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
STI - Solidion Technology Inc - Stock Price Chart
TickerSTI [NASD]
CompanySolidion Technology Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap122.79MEPS (ttm)-3.66
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y2.60%
P/B-EPS Q/Q-9438.89%
Dividend-Sales Q/Q-
Insider Own86.91%Inst Own1.56%
Insider Trans0.00%Inst Trans0.59%
Short Float6.45%EarningsApr 12/b
Analyst Recom-Target Price-
Avg Volume4.46M52W Range0.37 - 13.85
Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on December 14, 2023 and is headquartered in Dallas, TX.
PALI - Palisade Bio Inc - Stock Price Chart
TickerPALI [NASD]
CompanyPalisade Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap4.31MEPS (ttm)-28.25
P/E-EPS this Y46.67%
Forward P/E-EPS next Y-19.79%
PEG-EPS past 5Y75.28%
P/S17.24EPS next 5Y-
P/B0.28EPS Q/Q76.46%
Dividend-Sales Q/Q-
Insider Own1.75%Inst Own15.52%
Insider Trans201.68%Inst Trans-
Short Float0.22%EarningsMar 27/b
Analyst Recom1.00Target Price22.50
Avg Volume678.87K52W Range3.82 - 36.60
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finley John DavidCEO, CFO, DirectorMar 11 '24Option Exercise0.005,558096,849Mar 12 06:29 PM
Neal James RDirectorFeb 09 '24Option Exercise0.0010,920010,920Feb 13 03:08 PM
Diaz StephanieDirectorFeb 08 '24Option Exercise0.0012,800012,800Feb 13 03:08 PM
Csimma CristinaDirectorFeb 08 '24Option Exercise0.0012,800012,862Feb 13 03:08 PM
Trenschel Robert J.DirectorFeb 08 '24Option Exercise0.0010,920010,920Feb 13 03:08 PM
SCLX - Scilex Holding Company - Stock Price Chart
TickerSCLX [NASD]
CompanyScilex Holding Company
CountryUSA
IndustryDrug Manufacturers - General
Market Cap149.57MEPS (ttm)-0.87
P/E-EPS this Y41.76%
Forward P/E-EPS next Y36.84%
PEG-EPS past 5Y-
P/S3.20EPS next 5Y-
P/B-EPS Q/Q-0.28%
Dividend-Sales Q/Q-
Insider Own38.09%Inst Own15.92%
Insider Trans0.00%Inst Trans-9.17%
Short Float6.40%Earnings-
Analyst Recom1.00Target Price6.83
Avg Volume936.69K52W Range0.90 - 14.65
Apr-16-24 09:00AM Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses (GlobeNewswire) -9.38%
Apr-09-24 09:00AM Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido and ELYXYB for Commercially Insured Patients and the addition of ELYXYB to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool (GlobeNewswire)
Mar-27-24 09:00AM Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend (GlobeNewswire) +6.62%
Mar-21-24 09:30AM Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients (GlobeNewswire)
Mar-20-24 11:00AM Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed (GlobeNewswire)
09:00AM Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba (GlobeNewswire)
Mar-19-24 09:00AM Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation (GlobeNewswire)
Mar-18-24 09:00AM Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB for Acute Treatment of Migraine With or Without Aura in Canada (GlobeNewswire)
Mar-15-24 02:45PM Scilex Holding Announces Issuance of Halal Certification for its ZTlido product by Circle H International, Inc. (GlobeNewswire)
09:00AM Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement (GlobeNewswire)
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
RANI - Rani Therapeutics Holdings Inc - Stock Price Chart
TickerRANI [NASD]
CompanyRani Therapeutics Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap157.54MEPS (ttm)-1.33
P/E-EPS this Y19.01%
Forward P/E-EPS next Y1.59%
PEG-EPS past 5Y0.28%
P/S-EPS next 5Y-9.40%
P/B12.24EPS Q/Q22.23%
Dividend-Sales Q/Q-
Insider Own55.48%Inst Own7.73%
Insider Trans0.63%Inst Trans6.72%
Short Float16.57%EarningsMar 20/a
Analyst Recom1.00Target Price9.67
Avg Volume115.30K52W Range1.82 - 8.75
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Imran TalatChief Executive OfficerDec 06 '23Buy2.2710,00022,700484,455Dec 07 05:18 PM
Imran TalatChief Executive OfficerDec 04 '23Buy2.575,00012,850474,455Dec 06 08:00 AM
Imran TalatChief Executive OfficerNov 29 '23Buy2.0520,00041,000469,455Dec 01 08:00 AM
South Cone Investments Limited10% OwnerNov 24 '23Buy2.015,265,16510,582,98212,131,554Dec 08 04:27 PM
Quiroga Cortes Isidoro Alfonso10% OwnerNov 24 '23Sale2.015,265,16510,582,9828,400Dec 08 04:29 PM
GENE - Genetic Technologies Ltd. ADR - Stock Price Chart
TickerGENE [NASD]
CompanyGenetic Technologies Ltd. ADR
CountryAustralia
IndustryDiagnostics & Research
Market Cap0.46MEPS (ttm)-28.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.28%
P/S0.08EPS next 5Y-
P/B2.86EPS Q/Q95.41%
Dividend-Sales Q/Q-7.17%
Insider Own-Inst Own12.56%
Insider Trans-Inst Trans-61.21%
Short Float-EarningsFeb 23/a
Analyst Recom1.00Target Price6.87
Avg Volume28.44K52W Range1.80 - 5.90
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
OCUL - Ocular Therapeutix Inc - Stock Price Chart
TickerOCUL [NASD, RUT]
CompanyOcular Therapeutix Inc
CountryUSA
IndustryBiotechnology
Market Cap870.97MEPS (ttm)-1.26
P/E-EPS this Y17.45%
Forward P/E-EPS next Y-3.15%
PEG-EPS past 5Y8.38%
P/S14.90EPS next 5Y-
P/B7.39EPS Q/Q-71.51%
Dividend-Sales Q/Q5.16%
Insider Own9.13%Inst Own45.02%
Insider Trans21.76%Inst Trans-1.60%
Short Float8.74%EarningsMar 11/a
Analyst Recom1.38Target Price15.50
Avg Volume2.07M52W Range2.00 - 11.31
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUMMER ROAD LLC10% OwnerFeb 26 '24Buy7.52930,8517,000,0008,591,401Feb 27 04:43 PM
Mattessich Antony C.President and CEOJan 31 '24Sale4.9518,33890,773427,943Feb 02 07:00 PM
Ozden Rabia GursesChief Medical OfficerJan 31 '24Sale4.957,76438,43292,767Feb 02 07:02 PM
Strassburger Philip C.General CounselJan 31 '24Sale4.956,83133,813109,218Feb 02 07:01 PM
Notman DonaldChief Financial OfficerJan 31 '24Sale4.956,43331,843139,932Feb 02 07:03 PM
SERV - Serve Robotics Inc - Stock Price Chart
TickerSERV [NASD]
CompanyServe Robotics Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume-52W Range- - -
Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.
SMXT - SolarMax Technology Inc. - Stock Price Chart
TickerSMXT [NASD]
CompanySolarMax Technology Inc.
CountryUSA
IndustrySolar
Market Cap339.60MEPS (ttm)0.01
P/E777.32EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.27EPS next 5Y-
P/B-EPS Q/Q-89.27%
Dividend-Sales Q/Q-15.21%
Insider Own39.30%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume316.09K52W Range3.50 - 15.88
SolarMax Technology, Inc. is an integrated solar and renewable energy company. The firm engages in the provision of global energy solutions for residential and commercial markets. Its solar products include home solar, SMX solar panels, home battery, and electric car charging. The firm operates through the following segments: the United States and China. The United States operations consist of the sale and installation of photovoltaic and battery backup systems for residential and commercial customers, and sales of LED systems and services to government and commercial users. The China operations consist of identifying and procuring solar farm projects for resale to third parties and performing EPC services for solar farm projects. The company was founded by David Hsu, Simon Yuan and Ching Liu in January 2008 and is headquartered in Riverside, CA.
IZM - Iczoom Group Inc - Stock Price Chart
TickerIZM [NASD]
CompanyIczoom Group Inc
CountryChina
IndustryElectronics & Computer Distribution
Market Cap48.55MEPS (ttm)0.17
P/E27.71EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y134.59%
P/S0.23EPS next 5Y-
P/B3.12EPS Q/Q-43.76%
Dividend-Sales Q/Q-37.14%
Insider Own42.47%Inst Own0.03%
Insider Trans0.00%Inst Trans-
Short Float1.41%Earnings-
Analyst Recom-Target Price-
Avg Volume717.00K52W Range2.01 - 52.21
ICZOOM Group, Inc. is an offshore holding company, which engages in conducting operations in China through its subsidiaries and engages in the sales of electronic component. It mainly does business through e-commerce trading platforms and sells two categories of electronic component products-semiconductor products and electronic equipment, tools and other products. The company semiconductor products primarily include various integrated circuit, discrete, passive components, optoelectronics, and equipment, tools and other electronic component products primarily include various electromechanical, maintenance, repair & operations ("MRO"), and various design tool. Its products are widely used by SMEs in the consumer electronic industry, Internet of Things ("IoT"), automotive electronics and industry control segment. The company also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance. The company was founded by Lei Xia and Duan Rong Liu on June 23, 2015 and is headquartered in Shenzhen, China.
BENF - Beneficient - Stock Price Chart
TickerBENF [NASD]
CompanyBeneficient
CountryUSA
IndustryAsset Management
Market Cap1.26BEPS (ttm)-279.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2136.65EPS next 5Y-
P/B-EPS Q/Q-363081.65%
Dividend-Sales Q/Q-
Insider Own72.26%Inst Own19.88%
Insider Trans19.02%Inst Trans0.75%
Short Float0.01%EarningsFeb 13/a
Analyst Recom-Target Price-
Avg Volume110.57K52W Range3.80 - 1320.00
Beneficient provides alternative asset, financial and investment services. It offers services to individual investors, wealth advisors, general partners, and institutional investors. The company was founded on June 6, 2023 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CANGANY PETER T JRDirectorFeb 21 '24Buy0.25200,00050,000200,000Feb 22 04:46 PM
CANGANY PETER T JRDirectorFeb 20 '24Buy0.26200,00052,000200,000Feb 22 04:46 PM
12345671020